Around the time that Logdberg ended her medical writing career, the current way of doing things in pharma started to implode due to the twin controversies surrounding Vioxx and antidepressants like Paxil and later because the number of new drugs being approved per year fell off a cliff.

FORBES: A Former Pharma Ghostwriter Speaks Out

This is reassuringly similar to the current film-based way of doing things, and appeals particularly to companies, such as Kodak, that already have a vast retail network in place and are trying to shore up sales of film and paper.

ECONOMIST: Digital photography